Migraine treatment gets a rethink: New guide prioritizes patient voice and choice
A migraine headache can easily bring someone's usual day to a halt. The intense throbbing pain, usually on one side of the head, often comes with nausea, vision disturbances and light sensitivity. Preventive medicines work behind the scenes, aiming to reduce how often migraines strike rather than stopping an attack already underway.
Migraine headaches, characterized by throbbing pain on one side of the head, can disrupt daily activities due to nausea, vision disturbances and sensitivity to light. Preventive medications aim to reduce the frequency of these attacks rather than stopping them once they begin. Recently, a comprehensive guide was developed to help doctors and adult patients choose the right preventive medication for their individual needs and preferences.
A multidisciplinary panel of medical experts, including specialists, research methodologists and patient advocates, collaborated to create this guide. They carefully reviewed scientific evidence and answered three key questions about adults using daily preventive migraine drugs. The panel concluded that doctors should offer daily preventive medicines to patients experiencing four or more migraine days per month and to those who face significant daily disability, regardless of the number of headache days.
When selecting a preventive drug, the panel emphasized a collaborative approach. Doctors should suggest appropriate options based on the patient's medical and mental health history, existing medications, and potential side effects. They should inform patients about both established treatments like propranolol, topiramate and valproate, as well as newer migraine-specific treatments such as CGRP-targeting drugs available as pills or injections.
The guideline addressed various factors influencing drug selection, including comorbidities like fibromyalgia, obesity or high blood pressure, as well as age-related considerations for older adults and pregnant or breastfeeding individuals. It also took into account sex-related factors, advising care providers to warn female patients about potential risks of certain medications, such as valproate increasing the risk of polycystic ovary syndrome (PCOS).
The experts highlighted that providing time for preventive medications to show their full effect is crucial; standard daily medicines should be given at a tolerated dose for at least eight to 12 weeks before judging their effectiveness, while Botox requires 24 weeks at a tolerated dose before making that determination. They stressed that treatment decisions should be tailored to the individual patient and made in the context of their overall care, but the recommendations serve as voluntary guidelines for doctors to follow.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
